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A 75-year-old male who was undergoing chronic hemodialysis developed abrupt-onset pitting edema and pain in the dorsum of
both hands and feet. Biochemical analysis disclosed increased C-reactive protein, and negative rheumatoid factor and antinuclear
antibody. Radiological examination showed no bony erosion. Computed tomography and gallium scintigraphy revealed no active
infection or neoplasms. The clinical diagnosis was remitting seronegative symmetrical synovitis with pitting edema (RS3PE)
syndrome. The pitting edema and inﬂammatory response quickly subsided after low-dose prednisolone therapy. This case
demonstrates that RS3PE syndrome could be a diﬀerential diagnosis in elderly patients undergoing dialysis who develop pitting
edema and joint pain.
1.Introduction
Remitting seronegative symmetrical synovitis with pitting
edema (RS3PE) syndrome is a distinct disease entity that was
ﬁrstdescribedbyMcCartyetal.in1985[1].RS3PEsyndrome
is characterized by symmetrical and acute synovitis, marked
pitting edema, the absence of rheumatoid arthritis, increased
acute phase reactants, lack of bony erosions on radiography,
and a benign and short clinical course, as evidenced by quick
responsivenesstolow-doseprednisolonetreatmentandgood
prognosis after tapering oral prednisolone [2]. Although
dialysis patients often experience articular pain related to
amyloidosis and other musculoskeletal disorders [3], RS3PE
syndrome has rarely been reported.
We describe here the case of a hemodialysis patient who
developed acute-onset pitting edema in the dorsum of the
bilateralhandsandfeet.HewasﬁnallydiagnosedwithRS3PE
syndrome and was successfully treated with low-dose oral
prednisolone.
2.CaseReport
A 75-year-old male with a 23-year history of chronic
hemodialysis for end-stage renal failure developed acute-
onset bilateral wrist pain, accompanied by dorsal edema
of the bilateral hands and feet, increased acute phase
reactants, and low-grade fever. These symptoms started 3
months before admission. His past medical history included
coronary artery bypass grafting and aortic valve replacement
3 years prior to admission. The pitting edema was initially
attributed to extracellular ﬂuid overload, but persisted after
the volume status was adjusted.
On admission, the patient was alert, his blood pressure
was 108/60mmHg, heart rate was 64 beats per minute, and
bodytemperaturewas36.8◦C.Physicalexaminationrevealed
bilateral swelling of the hands and feet with pitting edema
(Figure 1). He also showed minimal tenderness and tenosyn-
ovial thickening at the wrist, and metacarpophalangeal
and proximal interphalangeal joint tenderness. Laboratory2 Case Reports in Medicine
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Figure 1: Photographs of the bilateral hands and feet. Edematous hands and feet with pitting edema were observed.
test results disclosed serum levels of C-reactive protein of
12.8mg/dL, hemoglobin of 8.5g/dL, white blood cell count
of8400/μLwithneutrophils78%,albumin2.4g/dL,andtotal
protein 5.6g/dL. Rheumatoid factor, antinuclear antibody
and anti-Scl-70 antibody were all negative. The results
of γ-interferon-release assay, repeated blood cultures, and
serum procalcitonin test were negative. Plain X-radiography
showed no joint erosion in either hand. Enhanced computed
tomographyshowednosignsofneoplasmoractiveinfection.
No accumulation in the juxta-articular regions was found
on gallium scintigraphy. After active infection and neoplasm
were ruled out, the patient was ﬁnally diagnosed with RS3PE
syndrome [1, 2].
Twenty mg/day of oral prednisolone was initiated on the
12th hospital day, after which the wrist pain and pitting
edema immediately subsided, followed by a decrease in
serumC-reactiveproteinlevelsto0.3mg/dLonthe28thhos-
pital day. At 6 months after discharge, the prednisolone dose
was gradually tapered to 5mg/day, and the patient remained
free from pitting edema and joint pain.
3. Discussion
The etiology of RS3PE syndrome remains unclear. However,
recent clinical studies have clariﬁed some aspects of its
pathogenesis. Cantini et al. revealed that tenosynovitis of
both extensor and ﬂexor tendons were involved in the
development of edema of the subcutaneous and peritendi-
nous soft tissue, and that the predominance of extensor
tenosynovitis at the wrist and feet is a hallmark of RS3PE
syndrome [4]. Arima et al. recently showed that vascular
endothelial growth factor played a role in the pathological
changes responsible for both hypervascularity (synovitis)
and vascular permeability (subcutaneous pitting edema)
[5]. In addition, possible associations with HLA B7 and
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been identiﬁed, indicating the involvement of autoimmune
processes in the pathogenesis of RS3PE syndrome.
Recent advances in imaging technology have contributed
to the accurate diagnosis of RS3PE syndrome, because
importantpathologicalﬁndingssuchassubcutaneousedema
and tissue thickening, tenosynovitis, subcutaneous ﬂuid col-
lection, dilatation of lymphatic vessels, and increased blood
ﬂow, cannot be fully detected by physical examination [4,
8]. Ultrasonography and magnetic resonance imaging can
sometimes detect these disease-related changes, but both
these imaging modalities are associated with advantages and
disadvantages [8]. Thus, the appropriate and combined use
of physical examination and imaging techniques should be
used to aid the early diagnosis of RS3PE syndrome.
A clinical diagnosis of RS3PE syndrome should be
made with care, because the clinical presentation of several
diseaseentities,suchaspolymyalgiarheumatica(PMR),late-
onset rheumatoid arthritis, and other rheumatic disorders
(spondyloarthropathies, psoriatic arthritis, and sarcoidosis)
can occasionally mimic that of RS3PE syndrome [9]. PMR is
an important disease entity that aﬀects the elderly, and also
manifests as increased serum inﬂammatory markers, onset
in older age, proximal muscle pain, and rapid response to
low-dose prednisolone. Diﬀerentiation between PMR and
RS3PE syndrome may be diﬃcult, but could be conﬁrmed
by the extension of the synovitis and the presence of distal
pitting edema, the predominance of peripheral arthritis, a
good, rapid responsiveness to low-dose oral prednisolone
without relapse, and lack of concomitant neoplasm. How-
ever, Salvarani et al, in a retrospective cohort study of
245 patients with PMR, reported a prevalence of extremity
swelling with pitting edema in 19 (8%) of patients [10].
They concluded that the distal swelling with pitting edema in
patients were peripheral manifestations of the inﬂammatory
process associated with PMR, most likely due to vigorous
tenosynovitis. Actually, some clinicians have recently insisted
that RS3PE syndrome may be a feature of diﬀerent diseases,
and not a distinct disease entity [11]. Further clinical
examinations are thus required to determine whether or not
RS3PE syndrome is a distinct disease, or merely a clinical
feature of diﬀerent inﬂammatory diseases.
Finally, RS3PE syndrome has not previously been re-
ported in dialysis patients. This is probably because RS3PE
syndrome is a relatively rare disease that is not well known
in the nephrology community. In addition, dialysis patients
caneasily be underdiagnosed, because acute-onset wristpain
with distal pitting edema might be attributed to simple
accumulation of extracellular ﬂuid and arthritis related
to amyloidosis or chronic inﬂammation, which are often
seen in patients on long-term dialysis. The present case
reportthusemphasizestheimportanceofconsideringRS3PE
syndrome as a potential diﬀerential diagnosis in dialysis
patients presenting with acute arthritis with pitting edema
in the distal extremities.
In conclusion, we report here a case of a chronic hemo-
dialysis patient who developed RS3PE syndrome. This case
suggests that RS3PE syndrome should be considered in the
diﬀerential diagnosis of polyarthritis in dialysis patients who
present with abrupt-onset synovitis and pitting edema in
the dorsum of the bilateral extremities, fever, and increased
inﬂammatory response.
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